Bioceltix S.a. Bioceltix S.a.

Bioceltix S.a.

BCX

Rank in Stocks #19653
Bioceltix S.A. engages in the development of stem cell-based biopharmaceuticals... Bioceltix S.A. engages in the development of stem cell-based biopharmaceuticals for veterinary use. The companyโ€™s products include BCX-CM-J, a stem-cell based biological drug for the treatment of osteoarthritis in dogs; BCX-CM-AD, a drug candidate based on allogeneic stem cells for the treatment of atopic dermatitis in dogs; and BCX-EM, a drug candidate based on allogeneic mesenchymal stem cells for the treatment of arthritis in horses. The company was founded in 2016 and is headquartered in Wroclaw, Poland.
Share Price
$17.22
Last synced: 2026-11-16
Market Cap
$95.26M
Change (1 day)
-2.06%
Change (1 year)
-30.27%
Country

Stock data: Financial Modeling PrepยทUpdated ยทNot investment adviceยทHow we calculate this

Category

Healthcare
Operating Margin for Bioceltix S.a. (BCX)
Operating Margin as of November 2026 TTM: 0.00%
According to Bioceltix S.a.'s latest financial reports, its current operating margin (TTM) is 0.00%. At the end of 2025 the company had an operating margin of 0.00%.
Operating Margin history for Bioceltix S.a. from 2018 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
2026 (TTM) 0.00% 0.00%
2025 0.00% 0.00%
2024 0.00% 0.00%
2023 0.00% 0.00%
2022 0.00% 0.00%
2021 0.00% -100.00%
2020 -36,934.63% -85.33%
2019 -251,764.00% 1,106.64%
2018 -20,864.88% 0.00%
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
33.87% -
US
-116.04% -
US
25.57% -
AU
31.23% -
BE
29.35% -
NL
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.

Questions about Bioceltix S.a.'s operating margin

What was Bioceltix S.a.'s operating margin in 2025?

In 2025, Bioceltix S.a.'s operating margin was 0.00%, compared with 0.00% in 2024.

How has Bioceltix S.a.'s operating margin changed since 2020?

From 2020 to 2025, Bioceltix S.a.'s operating margin was highest in 2025 (0.00%) and lowest in 2020 (-36,934.63%).

How does Bioceltix S.a.'s operating margin compare with similar companies?

Bioceltix S.a.'s operating margin (0.00%) is higher than that of 1 of the 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with 33.87%.